BioSpace News Archive

Theranica Bioelectronics (Theranica), a bio-medical technology company developing advanced electroceuticals for migraine and other pain conditions, and Cove, a healthcare company that provides increased access to innovative migraine treatments, alongside ongoing migraine management, announced today the expanded availability of Nerivio™,

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the fourth quarter and full year-ended December 31, 2019.

Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced Seven Bridges ARIA™, the first cloud-based solution aimed at improving and accelerating the discovery of meaningful connections between genomics, health data and biological knowledge at the 1M+ participant scale.

Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of Zhengzhou and City of Xinyang², in China, to help them better detect the coronavirus and monitor its mutations.

Advion Inc. today announces parent company Beijing Bohui Innovation Biotechnology Co., Ltd., has filed its intention to acquire Adchim SAS, the parent company of the Interchim group companies.

Pandion Therapeutics, Inc., a privately-held biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that company management will present at the upcoming Cowen & Co. 40th Annual Health Care Conference on Tuesday, March 3, 2020 at 4:30pm ET in Boston, MA.

Masimo (NASDAQ: MASI) and MS Westfalia GmbH (MSW) announced today that MSW will integrate additional Masimo measurement technologies into MSW’s plug-and-play hybrid Jenny platform, to help clinicians assess brain function, oxygenation, ventilation, and resuscitation status.

Sigilon Therapeutics, Inc., a biotechnology company developing functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced that Chief Executive Officer Rogerio Vivaldi, M.D., will discuss the company’s novel approach to cell therapy and outline upcoming clinical development plans at the 40th Annual Cowen & Co. Health Care Conference in Boston, Massachusetts.

Apnimed, a clinical-stage company focused on advancing pharmacologic treatments for sleep apnea and related disorders, today announced that Luigi Taranto Montemurro, M.D., a co-founder of the company, has joined the team full-time as Medical Director.

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2020 World’s Most Ethical Companies.